Decafluorobutane as a phase-change contrast agent for low-energy extravascular ultrasonic imaging.
about
Improving the performance of phase-change perfluorocarbon droplets for medical ultrasonography: current progress, challenges, and prospects.Phase-transition thresholds and vaporization phenomena for ultrasound phase-change nanoemulsions assessed via high-speed optical microscopy.Optically and acoustically triggerable sub-micron phase-change contrast agents for enhanced photoacoustic and ultrasound imagingAn evaluation of the sonoporation potential of low-boiling point phase-change ultrasound contrast agents in vitroDesign and Characterization of Fibrin-Based Acoustically Responsive Scaffolds for Tissue Engineering ApplicationsLipid Coated Microbubbles and Low Intensity Pulsed Ultrasound Enhance Chondrogenesis of Human Mesenchymal Stem Cells in 3D Printed ScaffoldsVaporization dynamics of volatile perfluorocarbon droplets: a theoretical model and in vitro validationPhase-change contrast agents for imaging and therapy.Nanodroplet-Vaporization-Assisted Sonoporation for Highly Effective Delivery of Photothermal Treatment.Application of acoustic droplet vaporization in ultrasound therapy.Biomimetic Acoustically-Responsive Vesicles for Theranostic Applications.Cavitation Enhancing Nanodroplets Mediate Efficient DNA Fragmentation in a Bench Top Ultrasonic Water Bath.Targeted drug delivery with focused ultrasound-induced blood-brain barrier opening using acoustically-activated nanodroplets.Phase-shift perfluorocarbon agents enhance high intensity focused ultrasound thermal delivery with reduced near-field heating.Sono-photoacoustic imaging of gold nanoemulsions: Part I. Exposure thresholds.Engineering optically triggered droplets for photoacoustic imaging and therapySynthesis of phase-shift nanoemulsions with narrow size distributions for acoustic droplet vaporization and bubble-enhanced ultrasound-mediated ablationAcoustic droplet-hydrogel composites for spatial and temporal control of growth factor delivery and scaffold stiffness.Toward ultrasound molecular imaging with phase-change contrast agents: an in vitro proof of principleThe impact of vaporized nanoemulsions on ultrasound-mediated ablationNanodroplet-mediated histotripsy for image-guided targeted ultrasound cell ablationMicrofluidic generation of acoustically active nanodroplets.Potential and problems in ultrasound-responsive drug delivery systems.High-speed, clinical-scale microfluidic generation of stable phase-change droplets for gas embolotherapy.Design of ultrasonically-activatable nanoparticles using low boiling point perfluorocarbons.Phase-change nanoparticles using highly volatile perfluorocarbons: toward a platform for extravascular ultrasound imagingPrecision manufacture of phase-change perfluorocarbon droplets using microfluidics.Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasoundPhase change events of volatile liquid perfluorocarbon contrast agents produce unique acoustic signatures.Dual-frequency acoustic droplet vaporization detection for medical imagingScavenging dissolved oxygen via acoustic droplet vaporization.In Situ Transfection by Controlled Release of Lipoplexes Using Acoustic Droplet VaporizationUltrasound-mediated strategies in opening brain barriers for drug brain delivery.Optimizing Acoustic Activation of Phase Change Contrast Agents With the Activation Pressure Matching Method: A Review.Contrast-enhanced ultrasound imaging and in vivo circulatory kinetics with low-boiling-point nanoscale phase-change perfluorocarbon agents.Wideband acoustic activation and detection of droplet vaporization events using a capacitive micromachined ultrasonic transducer.Intracellular delivery and ultrasonic activation of folate receptor-targeted phase-change contrast agents in breast cancer cells in vitro.In vitro and in vivo assessment of controlled release and degradation of acoustically responsive scaffolds.A general strategy for obtaining biodegradable polymer shelled microbubbles as theranostic devices.Methods of Generating Submicrometer Phase-Shift Perfluorocarbon Droplets for Applications in Medical Ultrasonography.
P2860
Q26861530-4CE3071A-9A09-478E-8933-501F10131215Q27308582-39C45BB4-4264-460D-A197-552D1478E075Q30356325-809AA2C1-7912-4509-BA38-240D2EE74849Q30364987-BE224029-3C65-4298-A03E-AD8B7D56C5CCQ30367078-5FBC3B7D-0657-4564-B356-47125372A004Q30369153-D441AC55-1E5E-47FC-9F8D-BF4D8621D8DAQ30370707-123B08B1-8E57-4597-A4EE-59F592A51150Q30373053-ECBC1B62-225E-4D95-AA39-FC286394676DQ30385124-548D6BF9-DF4D-4A07-BA0A-A5F2917D3B73Q30398863-0D6314BF-087C-4090-8691-ABA1A86B3A7BQ30402936-DE52520D-B47D-4160-9389-2B92CF7CC523Q30406409-F10A6F9E-1B12-437A-8600-47023FA29EA6Q30408959-5B442EF2-A972-46FC-B958-03ED6C2446A9Q30411555-09083E56-3193-4F42-9805-892B43071943Q30414163-636DB842-C016-4EC2-A05D-17E45AC90DD2Q30421094-626BF6BD-11F7-4742-9622-F5C75D7C1EDBQ30430901-B2867AA1-C9D0-43BD-9619-2E0CCF28F563Q30435509-572059F3-FA85-4D01-9342-4B4F9BD615A5Q30439339-94721B07-0906-4881-BBD6-C357A0EFC256Q30440014-7478A1B2-8526-4F68-A101-E27BD9C04944Q30446270-C8033FBC-3844-4AAE-992B-8CF1B432FF15Q30453206-FC0F9432-990F-402A-B0FB-79EBC52C4BC1Q30454986-8EA9893C-E938-4301-ABA9-77B6F31EE09BQ30455199-713837FA-AD2F-4A0C-8877-EC7FC1FCD598Q30455782-7123D63F-0FE9-465E-8B9F-1F1BAB6DBB81Q30458493-7D853A0C-B0FE-4530-A4BA-ABF53788F359Q30462010-C87672F3-1338-4894-9091-B4ED1D3F9650Q30463873-793CEB44-76B3-4A99-BFE4-7C1CBEC784D3Q33898006-77BEFF7E-BE85-4884-8DDA-3D2226088AC7Q33898022-17B3F85D-289F-429F-A005-CC8615659823Q36678959-4779DE04-D4F4-47BC-81F5-53F2DDCF995DQ37116079-9247E1AB-9C1D-4584-93FD-AA890309923CQ38095513-E0757D98-8588-4717-A356-AC53913099B5Q38980428-7E8F93D1-78D2-447E-A1EE-5011A6DA8BC4Q41066998-59A7D917-9B61-44B1-9975-80AF661AEA7DQ44865275-BFE17988-79D2-4C39-805D-67A18535E688Q44867216-339A66BE-C2F1-474F-B565-9B1233684D14Q45207717-74319B8A-E992-4A28-9DB4-49A60852E2FCQ45392313-7AE7BB8B-DEC3-48C8-8F0C-215A26F9D6C6Q47105144-8E1D2D2C-B979-468B-8CE9-97290884A8CA
P2860
Decafluorobutane as a phase-change contrast agent for low-energy extravascular ultrasonic imaging.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Decafluorobutane as a phase-ch ...... ravascular ultrasonic imaging.
@ast
Decafluorobutane as a phase-ch ...... ravascular ultrasonic imaging.
@en
type
label
Decafluorobutane as a phase-ch ...... ravascular ultrasonic imaging.
@ast
Decafluorobutane as a phase-ch ...... ravascular ultrasonic imaging.
@en
prefLabel
Decafluorobutane as a phase-ch ...... ravascular ultrasonic imaging.
@ast
Decafluorobutane as a phase-ch ...... ravascular ultrasonic imaging.
@en
P2093
P2860
P1476
Decafluorobutane as a phase-ch ...... ravascular ultrasonic imaging.
@en
P2093
Paul A Dayton
Ryan J McFarland
Samantha Luois
Steven Feingold
Terry O Matsunaga
Vincent P Wong
William D Ross
P2860
P304
P356
10.1016/J.ULTRASMEDBIO.2011.05.021
P577
2011-07-19T00:00:00Z